PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | – | 1,562 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1,562 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1,562 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1,562 | +2197.1% | 0.00% | – |
| Q1 2021 | $0 | – | 68 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 68 | -41.4% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 116 | -79.1% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 555 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 555 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 555 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 555 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -60.0% | 555 | -64.9% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 1,581 | +1.9% | 0.00% | – |
| Q4 2015 | $5,000 | – | 1,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |